The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Dr. Adams brings more than two decades of experience leading the manufacturing of biologic and gene therapies at all stages of development.
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
Subscribe To Our Newsletter & Stay Updated
